Skip to main content
SpringerLink
Log in

Off-Label Prescribing in Older People

The Need for Increased Awareness and Caution

  • Commentary
  • Published:
Drugs & Aging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Stafford RS. Regulating off-label drug use—rethinking the role of the FDA. New Engl J Med 2008; 358; 14: 1427–9

    Article  PubMed  CAS  Google Scholar 

  2. Jackson S, Jansen P, Mangoni A. Off-label prescribing in older patients. Drugs Aging 2012; 29 (6): 427–34

    Article  PubMed  CAS  Google Scholar 

  3. Rochon PA, Normand SL, Gomes T, et al. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 2008; 168 (10): 1090–6

    Article  PubMed  Google Scholar 

  4. Valiyeva E, Herrmann N, Rochon PA, et al. Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis. CMAJ 2008; 179 (5): 438–46

    PubMed  Google Scholar 

  5. Chen DT, Wynia MK, Moloney RM, et al. U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey. Pharmacoepidemiol Drug Saf 2009; 18: 1094–100

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by a Team Grant (OTG-88591) from the Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism and Diabetes. Dr Stephenson is supported by a CIHR post-doctoral fellowship salary support award. The authors have no conflicts of interest that are directly relevant to the content of this article.

Author information

Authors and Affiliations

  1. St. Michael’s Hospital, 30 Bond Street, 6th Floor, Toronto, Ontario, Canada, M5B 1W8

    Anne Stephenson

  2. Women’s College Hospital, Toronto, Ontario, Canada

    Anne Stephenson, Geoffrey M. Anderson & Paula Rochon

  3. Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada

    Geoffrey M. Anderson & Paula Rochon

  4. Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada

    Geoffrey M. Anderson & Paula Rochon

Authors
  1. Anne Stephenson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Geoffrey M. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paula Rochon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne Stephenson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stephenson, A., Anderson, G.M. & Rochon, P. Off-Label Prescribing in Older People. Drugs Aging 29, 435–436 (2012). https://doi.org/10.2165/11634620-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11634620-000000000-00000

Keywords

Search

Navigation